In silico methods of Molecular Docking, ADMET, DFT and MD simulations reveal the potential of cis-hydroxycinnamic acid derivatives as potent Acetylcholinesterase Inhibitors
In Silico Pharmacology · 03.11.2026 · 14 (3)
DOI: 10.1007/s40203-026-00769-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Silico Pharmacology, online erschienen am 03.11.2026. Verfasst von Shabir H Lone und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Government College for Women, MA Road, Srinagar, J & K 190001 India. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Acetylcholinesterase (AChE) remains one of the important targets for treating patients with Alzheimer's disease (AD). Currently there are no complete treatments available for the disease. This study is aimed to virtually identify novel cis-hydroxycinnamic acid with potential to inhibit AChE enzyme. A series of 21 alkyl/aryl derivatives of cis-o-hydroxycinnamic acid was hypothesized. The compounds were subjected to molecular docking using Auto Dock tools to find the binding interactions of the compounds with the target protein, acetylcholinesterase. About 14 compounds displayed predicted binding affinity ranging from - 9.83 to - 13.88 kcal/mol in comparison to standard Donepezil displaying ΔG of - 11.46 kcal/mol. Swiss ADME and Deep PK deduced their drug likeness and ADMET profile. The results of binding interactions were validated through DFT calculations using ORCA that helped to calculate various electronic parameters, frontier molecular orbitals and molecular electrostatic potential maps. Compounds 8, 9, 10, 11, 12, 13, 14 15, 16, 17, 18, 19, 20, 21 displayed appreciable binding interactions, majority of drug likeness parameters, optimal pharmacokinetic and electronic profile. However, the most balanced and favourable profile was observed for compounds 14 and 19 which demonstrated the need for evaluating the flexibility and structural rigidity of the docked complexes using Cabs-flex and IMODS. The docked complexes of both the compounds 14 and 19 revealed the optimal flexibility and physical movement. The findings in this study thus reveal that these derivatives of cis-o-hydroxycinnamic acid have the potential to act as promising acetylcholinesterase inhibitors. However, experimental studies need to be carried out to further validate this in silico study.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, Government College for Women, MA Road, Srinagar, J & K 190001 India.
- Natural Products and Medicinal Chemistry Division, CSIR IIIM, Jammu, J & K 180001 India.
- Department of Chemistry, Sri Pratap College, Srinagar, J & K 190001 India.
ORCID-Profile: Shabir H Lone
Zitieren
APA
Lone, S. H., Qayoom, B., Khanday, W. A., Farooq, S., Bhat, P. A., & Maqbool, M. (2026). In silico methods of Molecular Docking, ADMET, DFT and MD simulations reveal the potential of cis-hydroxycinnamic acid derivatives as potent Acetylcholinesterase Inhibitors. In Silico Pharmacology, 14(3). https://doi.org/10.1007/s40203-026-00769-3
Vancouver
Lone SH, Qayoom B, Khanday WA, Farooq S, Bhat PA, Maqbool M. In silico methods of Molecular Docking, ADMET, DFT and MD simulations reveal the potential of cis-hydroxycinnamic acid derivatives as potent Acetylcholinesterase Inhibitors. In Silico Pharmacology. 2026;14(3). doi:10.1007/s40203-026-00769-3
BibTeX
@article{Lone2026,
author = {Lone, Shabir H and Qayoom, Basit and Khanday, Waheed Ahmad and Farooq, Saleem and Bhat, Parvaiz Ahmad and Maqbool, Majida},
title = {In silico methods of Molecular Docking, ADMET, DFT and MD simulations reveal the potential of cis-hydroxycinnamic acid derivatives as potent Acetylcholinesterase Inhibitors},
journal = {In Silico Pharmacology},
year = {2026},
volume = {14},
number = {3},
doi = {10.1007/s40203-026-00769-3}
}
EUVIMED